The startup has developed a hand-held medical device that utilizes low-energy shockwave therapy to promote tissue regeneration in infarcted heart muscle. This technology enables cardiologists to enhance heart function in patients suffering from myocardial infarction.
Funding
$610K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Despite research in stem cell and gene therapies, effective regeneration of infarcted heart muscle remains a challenge, with existing technologies showing limited clinical results and potential side effects such as tumor formation. This unmet need leaves a significant gap in the treatment of myocardial infarction and ischemic heart failure.
Solution
Avenns Medical provides a device for cardiac shockwave therapy, designed to induce tissue regeneration in infarcted heart muscle and improve heart function, specifically the left ventricular ejection fraction (LVEF). The core technology is a sterile applicator suitable for direct cardiac application during coronary artery bypass graft (CABG) surgery. Low-energy shockwaves are delivered directly to the heart, promoting regeneration without the risks associated with other regenerative approaches. Clinical trials have demonstrated significant improvement in LVEF and patient quality of life.
Target Audience
The primary users are cardiac surgeons and interventional cardiologists performing CABG procedures, as well as hospitals and clinics specializing in cardiovascular care.
Features
- Hand-held applicator designed for direct cardiac application during CABG surgery
- Low-energy shockwave technology to stimulate tissue regeneration in infarcted heart muscle
- Precise and deep shockwave application
- Sterile, single-use applicator
- Demonstrated improvement in left ventricular ejection fraction (LVEF) in clinical trials (CAST-HF)
- Improved patient physical capacity, quality of life, and prolonged life expectancy